These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 29550639)

  • 1. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction.
    Marinello PC; da Silva TN; Panis C; Neves AF; Machado KL; Borges FH; Guarnier FA; Bernardes SS; de-Freitas-Junior JC; Morgado-Díaz JA; Luiz RC; Cecchini R; Cecchini AL
    Tumour Biol; 2016 Apr; 37(4):5337-46. PubMed ID: 26561471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroporation enhances cell death in 3D scaffold-based MDA-MB-231 cells treated with metformin.
    Sahu P; Camarillo IG; Dettin M; Zamuner A; Teresa Conconi M; Barozzi M; Giri P; Sundararajan R; Sieni E
    Bioelectrochemistry; 2024 Oct; 159():108734. PubMed ID: 38762949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemopreventive effect of the dietary compound kaempferol on the MCF-7 human breast cancer cell line is dependent on inhibition of glucose cellular uptake.
    Azevedo C; Correia-Branco A; Araújo JR; Guimarães JT; Keating E; Martel F
    Nutr Cancer; 2015; 67(3):504-13. PubMed ID: 25719685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
    Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism.
    Moreira L; Araújo I; Costa T; Correia-Branco A; Faria A; Martel F; Keating E
    Exp Cell Res; 2013 Jul; 319(12):1784-1795. PubMed ID: 23664836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent.
    Silva C; Andrade N; Guimarães JT; Patrício E; Martel F
    Eur J Pharmacol; 2021 May; 898():173980. PubMed ID: 33647254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
    Cai H; Everett RS; Thakker DR
    Br J Pharmacol; 2019 Aug; 176(15):2724-2735. PubMed ID: 31032880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
    Wokoun U; Hellriegel M; Emons G; Gründker C
    Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells' Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines.
    Banisharif Dehkordi F; Ghatrehsamani M; Abdolvand M; Soltani A; Masoumi SH
    Curr Pharm Des; 2024; 30(17):1341-1353. PubMed ID: 38676476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?
    Dogan Turacli I; Umudum H; Pampal A; Candar T; Kavasoglu L; Sari Y
    Mol Biol Rep; 2018 Jun; 45(3):195-201. PubMed ID: 29397517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
    Rajh M; Dolinar K; Miš K; Pavlin M; Pirkmajer S
    PLoS One; 2016; 11(5):e0154747. PubMed ID: 27135408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines.
    Markowicz-Piasecka M; Huttunen J; Sikora J; Huttunen KM
    Bioorg Chem; 2019 Jun; 87():321-334. PubMed ID: 30913467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
    Pacheco-Velázquez SC; Robledo-Cadena DX; Hernández-Reséndiz I; Gallardo-Pérez JC; Moreno-Sánchez R; Rodríguez-Enríquez S
    Mol Pharm; 2018 Jun; 15(6):2151-2164. PubMed ID: 29746779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
    Ariaans G; Jalving M; Vries EG; Jong S
    BMC Cancer; 2017 Mar; 17(1):232. PubMed ID: 28356082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
    Song W; Thakor P; Vesey DA; Gobe GC; Morais C
    Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes.
    Amaral MEA; Nery LR; Leite CE; de Azevedo Junior WF; Campos MM
    Invest New Drugs; 2018 Oct; 36(5):782-796. PubMed ID: 29392539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.